Nektar Therapeutics (NKTR)
73.18
-1.88
(-2.50%)
USD |
NASDAQ |
Mar 18, 16:00
73.20
+0.02
(+0.03%)
After-Hours: 06:52
Nektar Therapeutics Total Liabilities (Quarterly) : 190.57M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Rigel Pharmaceuticals, Inc. | 169.14M |
| Esperion Therapeutics, Inc. | 1.186B |
| Insmed, Inc. | 1.526B |
| Regeneron Pharmaceuticals, Inc. | 9.302B |
| Lyell Immunopharma, Inc. | 91.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 280.41M |
| Shareholders Equity (Quarterly) | 89.83M |
| Debt to Equity Ratio | 1.658 |
| Current Ratio | 4.974 |
| Net Debt Paydown Yield | 1.56% |